Microbiota and depressive disorders – a review
Open Access
- 16 February 2024
- journal article
- review article
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 60, 188-203
Abstract
Introduction: Depression, affecting 1 in 8 individuals with a 27.6% rise during COVID-19, prompts an exploration of the gut-brain-microbiota axis's role in mental health, focusing on depression.State of Knowledge: The gut microbiota regulates the brain-gut axis, impacting neurotransmitter production. Dysbiosis correlates with depressive behaviors. Factors like short-chain fatty acids and neurotrophins play roles in gut-brain communication.Materials and method: A literature review was conducted using the “PubMed” and “Google Scholar” databases with the keywords “Gut microbiota”, “Fecal microbiota”, “Depression and microbiota”, “Depression”, „Probiotics role”, „Mental health and priobiotics”, „Probiotics and prebiotics”, „Prebiotics and brain”.Summary: Altered gut microbiota links to psychiatric disorders, disrupting composition stability by age three through antibiotic use. Imbalances impact neurotransmitters and inflammation, crucial in depression pathophysiology.Treatment and Impact on Gut Microbiota: Antidepressants affect gut microbiota diversity bidirectionally, offering potential tailored therapies. The Mediterranean diet correlates with lower depression risk. Excessive sugar intake triggers neuroinflammation.Fecal Microbiota Transplantation: FMT emerges as a promising depression treatment, reshaping gut microbiota and modulating the gut-brain axis. Lactobacillus and Bifidobacterium spp. show potential in mitigating depression symptoms. FOS and GOS positively influence gut microbiota.Conclusion: This review underscores the intricate gut-brain-microbiota axis in depression, suggesting personalized therapeutic approaches for effective management.Keywords
This publication has 57 references indexed in Scilit:
- Toward a Deeper Understanding of Gut Microbiome in Depression: The Promise of Clinical ApplicabilityAdvanced Science, 2022
- Bacteroides species differentially modulate depression-like behavior via gut-brain metabolic signalingBrain, Behavior, and Immunity, 2022
- Gut microbiota is involved in the antidepressant effects of adipose-derived mesenchymal stem cells in chronic social defeat stress mouse modelPsychopharmacology, 2022
- A next-generation probiotic: Akkermansia muciniphila ameliorates chronic stress–induced depressive-like behavior in mice by regulating gut microbiota and metabolitesApplied Microbiology and Biotechnology, 2021
- Perturbations in Gut Microbiota Composition in Psychiatric DisordersJAMA Psychiatry, 2021
- A role of the subdiaphragmatic vagus nerve in depression-like phenotypes in mice after fecal microbiota transplantation from Chrna7 knock-out mice with depression-like phenotypesBrain, Behavior, and Immunity, 2021
- Ibrutinib alleviates LPS-induced neuroinflammation and synaptic defects in a mouse model of depressionBrain, Behavior, and Immunity, 2021
- Altered gut bacterial–fungal interkingdom networks in patients with current depressive episodeBrain and Behavior, 2020
- Clostridium butyricum miyairi 588 has preventive effects on chronic social defeat stress-induced depressive-like behaviour and modulates microglial activation in miceBiochemical and Biophysical Research Communications, 2019
- In vitro evaluation of single- and multi-strain probiotics: Inter-species inhibition between probiotic strains, and inhibition of pathogensAnaerobe, 2012